1. Aneuploidy, TP53 mutation, and amplification of MYC correlate with increased intratumor heterogeneity and poor prognosis of breast cancer patients. Issue 4 (9th January 2018) Authors: Oltmann, Johanna; Heselmeyer‐Haddad, Kerstin; Hernandez, Leanora S.; Meyer, Rüdiger; Torres, Irianna; Hu, Yue; Doberstein, Natalie; Killian, J. Keith; Petersen, David; Zhu, Yuelin Jack; Edelman, Daniel C.; Meltzer, Paul S.; Schwartz, Russell; Gertz, E. Michael; Schäffer, Alejandro A.; Auer, Gert;... Journal: Genes, chromosomes & cancer Issue: Volume 57:Issue 4(2018) Page Start: 165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cell-Derived Nanoparticles are Endogenous Modulators of Sepsis With Therapeutic Potential. Issue 3 (September 2017) Authors: Kunz, Natalia; Xia, Brent T.; Kalies, Kai-Uwe; Klinger, Matthias; Gemoll, Timo; Habermann, Jens K.; Whitacre, Brynne E.; Seitz, Aaron P.; Kalies, Kathrin; Caldwell, Charles C. Journal: Shock Issue: Volume 48:Issue 3(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Chromosomal Aneuploidy Affects the Global Proteome Equilibrium of Colorectal Cancer Cells. (2013) Authors: Gemoll, Timo; Habermann, Jens K.; Becker, Susanne; Szymczak, Silke; Upender, Madhvi B.; Bruch, Hans-Peter; Hellman, Ulf; Ried, Thomas; Auer, Gert; Jörnvall, Hans; Roblick, Uwe J. Journal: Analytical cellular pathology Issue: Volume 36:Number:5/6(2013) Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Expression of DIAPH1 is up‐regulated in colorectal cancer and its down‐regulation strongly reduces the metastatic capacity of colon carcinoma cells. Issue 7 (8th October 2013) Authors: Lin, Yuan‐Na; Izbicki, Jakob R.; König, Alexandra; Habermann, Jens K.; Blechner, Christine; Lange, Tobias; Schumacher, Udo; Windhorst, Sabine Journal: International journal of cancer Issue: Volume 134:Issue 7(2014:Apr. 01) Page Start: 1571 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. How clinical biobanks can support precision medicine: from standardized preprocessing to treatment guidance. Issue 6 (2nd November 2019) Authors: Flügge, Friedemann; Figge, Lena; Duhm-Harbeck, Petra; Kammler, Rosita; Habermann, Jens K. Journal: Expert review of precision medicine and drug development Issue: Volume 4:Issue 6(2019) Page Start: 309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Objective method of comparing DNA microarray image analysis systems. (June 2004) Authors: Korn, Edward L.; Habermann, Jens K.; Upender, Madhvi B.; Ried, Thomas; McShane, Lisa M. Journal: Biotechniques Issue: Volume 36:Number 6(2004) Page Start: 960 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Possibilities and limitations of 2DE‐based analyses for identifying low‐abundant tumor markers in human serum and plasma. Issue 19 (12th September 2016) Authors: Strohkamp, Sarah; Gemoll, Timo; Habermann, Jens K. Editors: Kalvodova, Lucie Journal: Proteomics Issue: Volume 16:Issue 19(2016) Page Start: 2519 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The impact of pre-analytical conditions on the serum proteome: heat-stabilization versus nitrogen storage. (July 2013) Authors: Gemoll, Timo; Löwe, Oliver; Borén, Mats; Oberländer, Martina; Hartwig, Sonja; Lehr, Stefan; Roblick, Uwe J.; Auer, Gert; Jörnvall, Hans; Habermann, Jens K. Journal: Archives of physiology and biochemistry Issue: Volume 119:Number 3(2013) Page Start: 100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗